Canadian Trends in Estimated Pharmaceutical Drug Purchases and Projections: 2023

In 2021, our group presented the first forecast of trends in Canadian pharmaceutical market. The goal was to identify factors that may influence future spending support public and private decision-makers predicting growth national drug purchases. This report is annual update estimated purchases Canada for 2022–2023. We conducted a time series analysis across between 2001 2021 using IQVIA’s Drugstore Hospital Purchases Audit, calculated total relative percentage change annually retail hospital sectors, forecasted 2023. Total were approximately $35.4 billion, 8.3% higher than 2020 (7.3% sector; 12.4% sector). Spending top 25 drugs 31.2% 52.3% respectively. sector continued moderate levels (7% 8% annually), with rates (12% 13% annually) setting. New approvals specialty oncology generic formulations are expected If no action taken curb sustained Canada, costs necessitate shift from other budgets or industry directly patients.